Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.
- First Posted Date
- 2022-12-12
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Albimmune SL
- Registration Number
- NCT05645887
News
No news found